1. Guidelines for the evaluation and management of a patient who presents with dyspeptic or ulcer-like symptoms. (COX-2, cyclooxygenase-2; GERD, gastroesophageal reflux disease; H2RA, H2-receptor antagonist; NSAID, nonsteroidal antiinflammatory drug; NUD, nonulcer dyspepsia; PPI, proton pump inhibitor.) (From Love B, Thoma MN. Peptic ulcer disease. In: DiPiro JT, Talbert RA, Yee GC, et al, eds. Pharmacotherapy: A Pathophysiologic Approach, 9th ed. New York, NY: McGraw-Hill, 2014; with permission.
Source: Peptic Ulcer Disease, Pharmacotherapy Principles & Practice, 4e
Citation: Chisholm-Burns MA, Schwinghammer TL, Wells BG, Malone PM, Kolesar JM, DiPiro JT. Pharmacotherapy Principles & Practice, 4e; 2016 Available at: Accessed: November 03, 2017
Copyright © 2017 McGraw-Hill Education. All rights reserved